Relationships between cortisol, dehydroepiandrosterone sulphate and insulin-like growth factor-I system in dementia - PubMed (original) (raw)

Comparative Study

doi: 10.1007/BF03343833.

Affiliations

• PMID: 11314741
• DOI: 10.1007/BF03343833

Comparative Study

Relationships between cortisol, dehydroepiandrosterone sulphate and insulin-like growth factor-I system in dementia

G Murialdo et al. J Endocrinol Invest. 2001 Mar.

Abstract

Changes in the hypothalamus-pituitary-adrenal axis (HPAA) function, entailing elevated cortisol circulating titres, occur in aging and in some neurological conditions, such as Alzheimer's disease (AD). Excess cortisol has neurotoxic effects which affect hippocampal neurones. Dehydroepiandrosterone sulphate (DHEAS) has an antiglucocorticoid activity and neuroprotective effects, but its levels decrease with aging. Glucocorticoids influence the production of insulin-like growth factor-I (IGF-I) and modify its systemic and neurotrophic biological activity by inducing changes in IGF-binding proteins (IGFBPs). We looked for relationships between cortisol, DHEAS levels, and IGF-I - IGFBPs system in AD. Cortisol, DHEAS and GH levels at 02:00, 08:00, 14:00, 20:00 h, basal IGF-I, IGFBP-1 and IGFBP-3 levels were determined by RIAs or IRMA in 25 AD patients, aged 58-89 yr, and in 12 age-matched healthy controls. AD subjects had higher cortisol, lower DHEAS levels and increased cortisol/DHEAS ratio (C/Dr) than controls. In AD cases, total IGF-I, IGFBP-3, and IGF-I/IGFBP ratios were significantly lowered, while IGFBP-1 levels were significantly higher than in controls. We found a significant inverse correlation between IGF-I and IGFBP-3 levels vs C/Dr, and between both IGF-I/IGFBPs ratios vs mean cortisol levels. IGFBP-3 correlated directly with DHEAS. Cortisol was directly and IGF-I inversely correlated with cognitive impairment. In AD patients we found that alterations in HPAA function and elevated C/Dr are related to lowered total and free IGF-I levels. These findings and their relationship to cognitive impairment suggest that changes in hormonal set-up might influence the clinical presentation of the disease.

PubMed Disclaimer

Similar articles

• Dexamethasone effects on cortisol secretion in Alzheimer's disease: some clinical and hormonal features in suppressor and nonsuppressor patients.
  Murialdo G, Barreca A, Nobili F, Rollero A, Timossi G, Gianelli MV, Copello F, Rodriguez G, Polleri A. Murialdo G, et al. J Endocrinol Invest. 2000 Mar;23(3):178-86. doi: 10.1007/BF03343703. J Endocrinol Invest. 2000. PMID: 10803476 Clinical Trial.
• Hippocampal perfusion and pituitary-adrenal axis in Alzheimer's disease.
  Murialdo G, Nobili F, Rollero A, Gianelli MV, Copello F, Rodriguez G, Polleri A. Murialdo G, et al. Neuropsychobiology. 2000;42(2):51-7. doi: 10.1159/000026672. Neuropsychobiology. 2000. PMID: 10940758 Clinical Trial.
• Age-related changes of the adrenal secretory pattern: possible role in pathological brain aging.
  Ferrari E, Casarotti D, Muzzoni B, Albertelli N, Cravello L, Fioravanti M, Solerte SB, Magri F. Ferrari E, et al. Brain Res Brain Res Rev. 2001 Nov;37(1-3):294-300. doi: 10.1016/s0165-0173(01)00133-3. Brain Res Brain Res Rev. 2001. PMID: 11744094 Review.
• Growth hormone and insulin-like growth factor-I as an endocrine axis in Alzheimer's disease.
  Gómez JM. Gómez JM. Endocr Metab Immune Disord Drug Targets. 2008 Jun;8(2):143-51. doi: 10.2174/187153008784534367. Endocr Metab Immune Disord Drug Targets. 2008. PMID: 18537700 Review.

Cited by

• Neuroprotective Effects of Physical Activity: Evidence from Human and Animal Studies.
  Chieffi S, Messina G, Villano I, Messina A, Valenzano A, Moscatelli F, Salerno M, Sullo A, Avola R, Monda V, Cibelli G, Monda M. Chieffi S, et al. Front Neurol. 2017 May 22;8:188. doi: 10.3389/fneur.2017.00188. eCollection 2017. Front Neurol. 2017. PMID: 28588546 Free PMC article. Review.
• Insulin and IGF-I prevent brain atrophy and DNA loss in diabetes.
  Serbedzija P, Madl JE, Ishii DN. Serbedzija P, et al. Brain Res. 2009 Dec 15;1303:179-94. doi: 10.1016/j.brainres.2009.09.063. Epub 2009 Sep 23. Brain Res. 2009. PMID: 19781531 Free PMC article.
• Conjugated Linoleic Acid Administration Induces Amnesia in Male Sprague Dawley Rats and Exacerbates Recovery from Functional Deficits Induced by a Controlled Cortical Impact Injury.
  Geddes RI, Hayashi K, Bongers Q, Wehber M, Anderson IM, Jansen AD, Nier C, Fares E, Farquhar G, Kapoor A, Ziegler TE, VadakkadathMeethal S, Bird IM, Atwood CS. Geddes RI, et al. PLoS One. 2017 Jan 26;12(1):e0169494. doi: 10.1371/journal.pone.0169494. eCollection 2017. PLoS One. 2017. PMID: 28125600 Free PMC article.
• Dementia: a neuroendocrine perspective.
  Polleri A, Gianelli MV, Murialdo G. Polleri A, et al. J Endocrinol Invest. 2002 Jan;25(1):73-83. doi: 10.1007/BF03343964. J Endocrinol Invest. 2002. PMID: 11883869 Review.
• The therapeutic potential of insulin-like growth factor-1 in central nervous system disorders.
  Costales J, Kolevzon A. Costales J, et al. Neurosci Biobehav Rev. 2016 Apr;63:207-22. doi: 10.1016/j.neubiorev.2016.01.001. Epub 2016 Jan 15. Neurosci Biobehav Rev. 2016. PMID: 26780584 Free PMC article. Review.

References

1. 1. Br J Psychiatry. 1968 Jul;114(512):797-811 - PubMed
2. 1. J Clin Endocrinol Metab. 1998 Oct;83(10):3487-92 - PubMed
3. 1. Front Neuroendocrinol. 1999 Jan;20(1):49-70 - PubMed
4. 1. Endocr Rev. 1998 Jun;19(3):269-301 - PubMed
5. 1. Lancet. 1988 Aug 13;2(8607):391-2 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Springer

• Medical

  • MedlinePlus Health Information

• Miscellaneous

  • NCI CPTAC Assay Portal